Allografting or autografting for myeloma. [N Engl J Med. 2007] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: N Engl J Med. 2007 Jun 21;356(25):2646-8; author reply 2646-8.Links

Comment on:: N Engl J Med. 2007 Mar 15;356(11):1110-20.

Allografting or autografting for myeloma.

van Rhee F, Crowley J, Barlogie B.

PMID: 17582078 [PubMed - indexed for MEDLINE]

Related articles

Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
Haematologica. 2005 Feb; 90(2):278-9.

[Haematologica. 2005]
High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
Haematologica. 2008 Mar; 93(3):455-8. Epub 2008 Feb 20.

[Haematologica. 2008]
Allografting or autografting for myeloma.
N Engl J Med. 2007 Jun 21; 356(25):2646-8; author reply 2646-8.

[N Engl J Med. 2007]
Review[Current therapy for multiple myeloma]
Pol Arch Med Wewn. 2005 Oct; 114(4):1030-6.

[Pol Arch Med Wewn. 2005]
ReviewTandem transplants in the treatment of multiple myeloma. Pro.
Clin Adv Hematol Oncol. 2004 May; 2(5):303-4.

[Clin Adv Hematol Oncol. 2004]
» See reviews... | » See all...

Patient Drug Information

Bortezomib (Velcade® )
Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Bortezomib is also used to treat people with mantle cell ly...
Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Allografting or autografting for myeloma.Allografting or autografting for myeloma.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show